Glenmark Pharmaceuticals rises on getting USFDA’s nod for Sodium Phenylbutyrate Tablets
Glenmark Pharmaceuticals is currently trading at Rs. 418.30, up by 5.10 points or 1.23% from its previous closing of Rs. 404.40 on the BSE. The scrip opened at Rs. 412.15 and has touched a high and low of Rs. 418.00 and Rs. 412.15 respectively. So far 8167 shares were traded on the counter. The BSE … Read more
